Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Aflibercept Injection for the Treatment of cHoroidAl Neovascularization seconDary to Presumed ocuLar Histoplasmosis syndromE.(the HANDLE Study)

NCT01790893 is registered in ClinicalTrials.gov with John Kitchens, MD as lead sponsor.

NCT NCT01790893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01790893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Aflibercept Injection for the Treatment of cHoroidAl Neovascularization seconDary to Presumed ocuLar Histoplasmosis syndromE.(the HANDLE Study)
Lead sponsor
John Kitchens, MD
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 31, 2013
Completion date
August 31, 2014
Enrollment
40 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ocular histoplasmosis